Table of Contents

company-logo

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.

Alaunos Therapeutics Dividend Announcement

• Alaunos Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Alaunos Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Alaunos Therapeutics Dividend History

Alaunos Therapeutics Dividend Yield

Alaunos Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alaunos Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Alaunos Therapeutics Financial Ratios

P/E ratio-0.32
PEG ratio0.02
P/B ratio1.39
ROE-267.77%
Payout ratio0.00%
Current ratio4.30
Quick ratio4.30
Cash Ratio2.04

Alaunos Therapeutics Dividend FAQ

Does Alaunos Therapeutics stock pay dividends?
Alaunos Therapeutics does not currently pay dividends to its shareholders.
Has Alaunos Therapeutics ever paid a dividend?
No, Alaunos Therapeutics has no a history of paying dividends to its shareholders. Alaunos Therapeutics is not known for its dividend payments.
Why doesn't Alaunos Therapeutics pay dividends?
There are several potential reasons why Alaunos Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Alaunos Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Alaunos Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Alaunos Therapeutics a dividend aristocrat?
Alaunos Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Alaunos Therapeutics a dividend king?
Alaunos Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Alaunos Therapeutics a dividend stock?
No, Alaunos Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Alaunos Therapeutics stocks?
To buy Alaunos Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Alaunos Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.